Michael Bogenschutz, MD
Enriched profileProfessor (Research) of Psychiatry, NYU School of Medicine · NYU School of Medicine
Michael Bogenschutz is Professor (Research) of Psychiatry, NYU School of Medicine at NYU School of Medicine. OpenAlex indexes 169 publications with 8,361 citations (h-index 40); ClinicalTrials.gov lists 11 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Psychiatry profiles in the findmyKOL directory.
Data verified 23 Oct 2026
Overview
Updated 24 Oct 2026
Michael Bogenschutz, MD, is Professor (Research) of Psychiatry, NYU School of Medicine. The public record shows 169 publications with 8,361 citations (h-index 40), centered on Substance Abuse Treatment and Outcomes, Opioid Use Disorder Treatment, Psychedelics and Drug Studies. It also documents an investigator role on 11 registered clinical trials, industry payments reported by 1 companies, 4 NIH-funded awards (2005–2014).
- Most recent indexed publication: 2026 · Nature medicine
- Top research focus: Substance Abuse Treatment and Outcomes
- 11 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 24 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 10 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 86.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 24 Oct 2026
Listed as an investigator on 11 registered studies on ClinicalTrials.gov. The most recent:
- Effects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who Stutter
Sponsor: NYU Langone Health
- Psilocybin for Opioid Use Disorder (OUD)
Sponsor: NYU Langone Health
- Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for AUD
Sponsor: NYU Langone Health
Industry payments
Updated 24 Oct 2026
1 company reported payments to CMS in program years 2025–2025. These are public disclosures, not judgments. The latest:
- Eli Lilly and CompanyProgram year20251 payment
NIH funding
Updated 24 Oct 2026
4 NIH research awards on record, funded 2005–2014 per NIH RePORTER. The latest:
- Neural mechanisms of psilocybin-assisted treatment for alcohol use disorder.
New York University School of Medicine
FY2026$652,030R01AA031417 - Evaluation of psilocybin as an adjunctive treatment for opioid use disorder in methadone-maintained patients who continue to use illicit opioids
New York University School of Medicine
FY2025$3,172,763UG3DA062088 - Neural mechanisms of psilocybin-assisted treatment for alcohol use disorder.
New York University School of Medicine
FY2025$665,785R01AA031417
Publications
Updated 24 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Effects of cannabidiol in alcohol use disorder patients with and without co-occurring post-traumatic stress disorder: Tolerability but no evidence for efficacy in two randomized proof-of-concept trials.
Alcohol, clinical & experimental research
Clinical Trial2026 - Exploring the role of gender on treatment outcomes in older adults with alcohol use disorder.
Alcohol, clinical & experimental research
Clinical Trial2025 - Relief craving severity moderates nonpharmacological treatment outcomes in treatment-seeking older adults with alcohol use disorder.
Alcohol, clinical & experimental research
Clinical Trial2025 - A clinical research perspective on the regulation of medical and non-medical use of psychedelic drugs.
Addiction (Abingdon, England)
Article2025
Most-cited works
by citation count (OpenAlex)- 01Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept studyArticle1,150 citations2015
- 02
- 03
- 04
- 05Amplification of a Gene Related to Mammalian mdr Genes in Drug-Resistant Plasmodium falciparumArticle444 citations1989
Network
Updated 24 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 24 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/michael-bogenschutz-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
physicianfocus.nyulangone.org/psilocybin-trial-for-alcohol-dependence
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physicianfocus.nyulangone.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 24 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →brightmindsbio.com ↗
Secondary affiliations
appointments beyond the home institution- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →med.nyu.edu ↗
- Director
NYU Langone Center for Psychedelic Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →brightmindsbio.com ↗ - Professor
Department of Psychiatry, NYU Grossman School of Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →med.nyu.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Charles Nemeroff, MD
Dell Medical School
Maurizio Fava, MD
Massachusetts General Hospital
John Krystal, MD
Yale University
Raquel Gur, MD
University of Pennsylvania